Evidence map›Paper›PMID 38977676›Full record

ArticleNature communications2024

tRNA m

Hongna Zuo, Aiwei Wu, Mingwei Wang, Liquan Hong, Hu Wang

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. mStem cell reviews and reports · 2026
    Article
  2. Article
  3. tRNA mEMBO reports · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. WDR5-H3K4me3 Epigenetic Axis Promotes TRMT6-Dependent tRNA MAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. The Secret Life of NJournal of molecular biology · 2025
    Review
  14. TRMT6-mediated tRNA mNature cancer · 2025
    Article
  15. mRNA translational control of regeneration.Current opinion in genetics & development · 2025
    Review
  16. Review
  17. Methylations in dilated cardiomyopathy and heart failure.Frontiers in cardiovascular medicine · 2025
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongna Zuo *Zhejiang Key Laboratory of Medical Epigenetics, School of Basic Medical Sciences, The Third People's Hospital of Deqing, Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 311121, China.ORCID 0009-0000-1820-4499
Aiwei Wu *Zhejiang Key Laboratory of Medical Epigenetics, School of Basic Medical Sciences, The Third People's Hospital of Deqing, Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 311121, China.ORCID 0000-0001-8531-4815
Mingwei WangZhejiang Key Laboratory of Medical Epigenetics, School of Basic Medical Sciences, The Third People's Hospital of Deqing, Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 311121, China.ORCID 0000-0001-9060-5107
Liquan HongZhejiang Key Laboratory of Medical Epigenetics, School of Basic Medical Sciences, The Third People's Hospital of Deqing, Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 311121, China.
Hu WangZhejiang Key Laboratory of Medical Epigenetics, School of Basic Medical Sciences, The Third People's Hospital of Deqing, Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 311121, China. wanghu19860315@163.com.ORCID 0000-0001-6053-0407

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82301746National Natural Science Foundation of China (National Science Foundation of China) 92249304
6 · The paper itself

Abstract

Haematopoietic stem cells (HSCs) possess unique physiological adaptations to sustain blood cell production and cope with stress responses throughout life. To maintain these adaptations, HSCs rely on maintaining a tightly controlled protein translation rate. However, the mechanism of how HSCs regulate protein translation remains to be fully elucidated. In this study, we investigate the role of transfer RNA (tRNA) m

Indexed as

Cell ProliferationHematopoietic Stem CellsMechanistic Target of Rapamycin Complex 1RNA, TransferSignal TransductionTuberous Sclerosis Complex 1 ProteinAnimalsCell Self RenewalMethylationMethyltransferasesMiceMice, Inbred C57BLMice, KnockoutMechanistic Target of Rapamycin Complex 1MethyltransferasesRNA, TransferTsc1 protein, mouseTuberous Sclerosis Complex 1 Protein

Identifiers

PMID38977676
PMCPMC11231335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.